Results 231 to 240 of about 18,026 (280)
Some of the next articles are maybe not open access.

Pattern of Phenylbutazone Degradation

Journal of Pharmaceutical Sciences, 1973
Phenylbutazone and phenylbutazone-antacid formulations were examined by TLC for the presence of decomposition products. A procedure was developed for minimizing on-plate oxidation of phenylbutazone during TLC analysis, and preparative TLC was utilized for isolation of the major products of decomposition. Unequivocal identification of the major products
F. Matsui, A. Vincent, D.V.C. Awang
openaire   +3 more sources

The Antithyroid Effect of Phenylbutazone

Acta Rheumatologica Scandinavica, 1956
SummaryOn 19 patients undergoing Phenylbutazone treatment, 600 mg. by mouth per day for various rheumatic complaints, the antithyroid effect of this drug was studied by the use of repeated tracer iodine tests. The uptake values were reduced after one week's treatment but this effect tended to revert after further treatment.
A.-M. Allgoth   +2 more
openaire   +3 more sources

Management of thrombophlebitis with phenylbutazone

The American Journal of Cardiology, 1959
I T IS my purpose to present a treatment for thrombophlebitis which aborts the clinical syndrome, cuts down on the need for nursing care and hospitalization, and has a potential for lessening the long term complications of venous thrombosis. These objectives are attained through the use of phenylhutazone,t a nonhormonal drug with anti-inflammatory ...
openaire   +3 more sources

AGRANULOCYTOSIS DUE TO PHENYLBUTAZONE

Annals of Internal Medicine, 1957
Excerpt It is well known that phenylbutazone is a hazardous medication, although it has been very effective therapeutically in relief of pain of arthritis and similar conditions.
R E Geesaman, F L James
openaire   +3 more sources

Misuse of Veterinary Phenylbutazone

Archives of Internal Medicine, 1995
Phenylbutazone is a nonsteroidal anti-inflammatory drug that was commonly prescribed for the treatment of arthritic conditions; it is no longer available for use in humans because of its numerous side effects, including aplastic anemia. We describe a horse trainer who developed gastric ulcers and renal insufficiency as a result of taking veterinary ...
W M McDonnell, S L Carpenter
openaire   +2 more sources

PHENYLBUTAZONE AND AGRANULOCYTOSIS

JAMA: The Journal of the American Medical Association, 1953
To the Editor: —I have just read with interest the report "Agranulocytosis Following Use of Phenylbutazone (Butazolidin ® )" by Hinz and others inThe Journal, Jan. 3, 1953, page 38. During the past year and a half, I have obtained a great deal of experience from using this drug in the treatment of over 700 patients with various arthritides and ...
openaire   +2 more sources

Effects of Phenylbutazone in Gout

New England Journal of Medicine, 1954
PHENYLBUTAZONE (3, 5-dioxo-l, 2–diphenyl4-n-butyl-pyrazolidin sodium) is a pyrazolon derivative with anti-inflammatory and analgesic properties.1 Its formula is as follows: Success with this drug in the treatment of gout has previously been reported by Gutman and Yu,2 by Kuzell et al.,3 , 4 and by Steinbrocker and his associates.5 In the past year we ...
Peter H. Forsham   +5 more
openaire   +3 more sources

Phenylbutazone and Indomethacin

Clinics in Rheumatic Diseases, 1975
SUMMARY This chapter reviews the demonstration of the analgesic and anti-inflammatory effects of phenylbutazone and indomethacin, and attempts to explain their mode of action in terms of effects on mediators of inflammation, tissue and cellular metabolism and reaction with protein molecules.
openaire   +2 more sources

Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E2 concentrations

Journal of Veterinary Pharmacology and Therapeutics, 2018
S. Pedersen   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy